#SomaticGenomics has near limitless possibilities in driving transformative treatments across a multitude of therapeutic areas. Learn more about how we are using our platform to advance target identification and #DrugDevelopment: https://bit.ly/3UzKYTP
Quotient Therapeutics’ Post
More Relevant Posts
-
How can we use discovery #proteomics to expand the possibilities of target identification? In our recent #webinar we walked through a use case example of proteomics-based target ID – including for discovery of novel targets – and importantly, approaches for enhanced target validation. Watch the clip below and download the full recording for more application examples! https://lnkd.in/eNgUxKaM #targetidentification #proteintargets #discovermore
-
Biotech Matchmaker: Enabling Drug Discovery & Development with Innovative Solutions | Charles River Laboratories
Explore an #antibody discovery case study on targeting antigens with highly homologous family members in our on-demand webinar. Charles River’s Kalyani Mondal covers how a diverse phage library and well-designed panning strategy helps against challenging antibody targets. Watch now: https://okt.to/GNT15b
-
-
Manager - Account Management Executives - Discovery and Safety Assessment - West Coast at Charles River Laboratories
Explore an #antibody discovery case study on targeting antigens with highly homologous family members in our on-demand webinar. Charles River’s Kalyani Mondal covers how a diverse phage library and well-designed panning strategy helps against challenging antibody targets. Watch now: https://okt.to/3Xmq9M
-
-
Life sciences and drug discovery business development focusing on global and emerging markets
Explore an #antibody discovery case study on targeting antigens with highly homologous family members in our on-demand webinar. Charles River’s Kalyani Mondal covers how a diverse phage library and well-designed panning strategy helps against challenging antibody targets. Watch now: https://okt.to/SfHNJ1
-
-
Explore an #antibody discovery case study on targeting antigens with highly homologous family members in our on-demand webinar. Charles River’s Kalyani Mondal covers how a diverse phage library and well-designed panning strategy helps against challenging antibody targets. Watch now: https://okt.to/qw3Wrg
-
-
Building Biopharma Business Relationships | Strategic Thinker | Leader for Workplace Wellbeing | People Oriented | UK Royal Voluntary Service Award
📣Antibody Discovery Webinar - watch below ⬇️
Explore an #antibody discovery case study on targeting antigens with highly homologous family members in our on-demand webinar. Charles River’s Kalyani Mondal covers how a diverse phage library and well-designed panning strategy helps against challenging antibody targets. Watch now: https://okt.to/qw3Wrg
-
-
📱Is social listening part of your qualitative patient research? Should it be? 🌱Sprout scientist Roxana Bahar, PhD evaluates the value of this tool for capturing insights from patient groups who tend to avoid traditional interviews, including marginalized and stigmatized communities, as well as teens. 🔗 Check out her infographic summarizing Pros & Cons of Social Media Listening here: https://lnkd.in/gQEyTndz 💬 For a more detailed discussion, read about our study on the use of social media listening for understanding patient experiences in chronic disease on SproutBlog, including access to download the full #ISPOR presentation: https://lnkd.in/gh_KE2Tm #SocialMediaListening #ChronicDisease #QualitativeResearch
-
More evidence the AI can assist in the development of #raredisease therapies.
Discovering safe and effective treatments for rare diseases presents a number of challenges, beginning with the sourcing and integration of diverse data sets that inform #drugdiscovery. We are excited to share our research on an experimentally validated approach to generating automated biological evidence using knowledge graphs has been published in Nature Communications. We extend our sincere gratitude to the Healx team members who are driving this novel approach forward. Check it out here. https://lnkd.in/eq-_YiyY
An experimentally validated approach to automated biological evidence generation in drug discovery using knowledge graphs - Nature Communications
nature.com
-
What could healthcare look like if we could detect diseases before they occur so that there’s a better chance of prevention or successful treatment? What could R&D look like if we could accelerate the discovery of novel biological targets to design better and more effective medicines? At AstraZeneca, we are asking those big questions and designing cutting-edge research tools to find the answers. Our Centre for Genomics Research just unveiled a new AI research tool, MILTON which is helping accelerate drug discovery and carries potential to transform early disease detection. Learn more: https://lnkd.in/ezWy7yni
-
